GTT Data Solutions appoints Dr. Charudatta Palwe as Independent Director

1 min read     Updated on 09 Jun 2026, 11:08 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

GTT Data Solutions appointed Dr. Charudatta Palwe as an Additional Independent Director effective June 9, 2026, for a five-year term subject to shareholder approval. Dr. Palwe, a medical doctor and biomedical engineer, meets all independence criteria under the Companies Act, 2013 and SEBI regulations. The board approved the appointment on June 8, 2026.

powered bylight_fuzz_icon
42529095

*this image is generated using AI for illustrative purposes only.

GTT Data Solutions has strengthened its board governance by appointing Dr. Charudatta Palwe as an Additional Independent Director. The appointment, effective June 9, 2026, is for a five-year term concluding on June 8, 2031, and remains subject to approval by the company's shareholders. This strategic move aims to bolster the board with independent oversight as the company continues its operations.

The Board of Directors approved the appointment through a resolution dated June 8, 2026. Dr. Palwe satisfies the criteria for independence prescribed under the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that he is not related to any existing director and is not debarred from holding the director position by any order from SEBI or other authorities.

Profile of the New Director

Dr. Charudatta Prabhakar Palwe brings a diverse professional background to the role. A medical doctor and biomedical engineer, he possesses expertise in healthcare administration, business development, and strategic planning. His experience spans operational management, budget control, and organizational leadership, with a focus on technology, marketing, and rural healthcare in India.

The appointment was disclosed to the stock exchanges in compliance with Regulation 30 of the SEBI LODR Regulations. The requisite details, including those required under SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, were submitted as part of the regulatory filing.

Appointment Details

Particulars Details
Name of Director Dr. Charudatta Prabhakar Palwe (DIN: 00532670)
Category Additional Independent Director
Date of Appointment June 9, 2026
Term of Appointment 5 years (June 9, 2026 to June 8, 2031)
Shareholder Approval Required

Historical Stock Returns for GTT Data Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
-2.53%-10.77%-20.63%-46.15%-50.37%+3,356.90%

How will Dr. Palwe's healthcare and technology expertise influence GTT Data Solutions' strategic direction?

What specific governance changes or committee roles can be expected following this appointment?

Is this appointment a precursor to a strategic pivot into healthcare technology or rural markets?

GTT Data Solutions explains delay in director exit disclosure

1 min read     Updated on 04 Jun 2026, 10:51 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

GTT Data Solutions Limited disclosed the reason for the delay in reporting the vacation of office of Independent Director Mr. Samarjeetsinh Vikramsinh Ghatge. The exit, effective August 14, 2025, was triggered by Section 167(1)(b) of the Companies Act, 2013, due to absence from meetings. The company identified the issue upon receiving the Annual Secretarial Compliance Report on May 30, 2026, and verified records before filing the disclosure on June 2, 2026.

powered bylight_fuzz_icon
41948466

*this image is generated using AI for illustrative purposes only.

GTT Data Solutions Limited provided an explanation for the delay in disclosing the vacation of office of Independent Director Mr. Samarjeetsinh Vikramsinh Ghatge, attributing the lapse to the timing of observations from its Annual Secretarial Compliance Report (ASCR). The director vacated his office on August 14, 2025, pursuant to Section 167(1)(b) of the Companies Act, 2013, due to absence from all Board meetings held over a twelve-month period. The company submitted the additional information to BSE Limited on June 4, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company stated that the applicability of Section 167(1)(b) was identified during a review of observations received from the Secretarial Auditor in connection with the ASCR, which was received on May 30, 2026. Following the receipt of the report, the company undertook a review of relevant records to ascertain the factual position and determine the applicable date of vacation of office.

Verification of records, including Board attendance records, commenced on June 1, 2026, the first working day after the ASCR was received. The company confirmed the applicability of the legal provision and the effective date of cessation before making the requisite disclosure on June 2, 2026. The submission asserts that the disclosure was made promptly upon identification and verification of the matter.

Details of Cessation

Particulars Details
Reason for change Vacation of office of Independent Director pursuant to Section 167(1)(b) of the Companies Act, 2013 on account of absence from all Board Meetings held during a period of twelve months.
Date of cessation 14 August, 2025
Brief profile Not Applicable
Relationship between Directors Not Applicable

The notification was signed by Ebrahim Saifuddin Nimuchwala, Company Secretary & Compliance Officer, on behalf of GTT Data Solutions Limited (formerly known as Cinerad Communications Limited).

Historical Stock Returns for GTT Data Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
-2.53%-10.77%-20.63%-46.15%-50.37%+3,356.90%

How will GTT Data Solutions fill the vacancy left by the Independent Director to ensure continued board governance?

What impact will this delayed disclosure have on investor confidence and the company's compliance rating?

Will the company implement additional internal controls to prevent similar delays in future statutory disclosures?

More News on GTT Data Solutions

1 Year Returns:-50.37%